Funded Research

The MRF has funded millions of dollars in melanoma research since 1998.

The Melanoma Research Foundation is proud to award research grants supporting the study of melanoma prevention, diagnosis and treatment across the spectrum of the disease, including cutaneous, ocular and mucosal melanoma. These include the following:

  • Team Awards (established in 2014) - Two-year awards, up to $250,000 per year
  • Established (Senior) Investigator Awards (established in 2006) - Two-year awards, up to $100,000 per year
  • Career Development (Junior) Awards (established in 1998) - Two-year awards, up to $50,000 per year
  • Medical Student Awards (established in 2011) - One-year awards, up to $3,000
  • Society for Melanoma Research Young Investigator Awards (sponsored by the MRF since 2013) - One-year awards, $5,000 per year
  • Society for Melanoma Research Christopher J. Marshall Award (sponsored by the MRF since 2015) - One-year awards, $5,000 per year

View a summary of the 2020 Research Recipients here.

Effect of the aged microenvironment on tumor dormancy 

Established Investigator Award 2015
Principal Investigator: Ashani Weeraratna, PhD
Institution: The Wistar Institute


MEK1/2-CDK4/6 targeting and acquired resistance mechanisms in NRAS melanoma 

Team Award 2015
Principal Investigator: Roger Lo, MD, PhD
Institution: UCLA Medical Center


Mechanisms controlling melanoma dormancy and metastatic progression

Team Award 2015
Principal Investigator: Marcus Bosenberg, MD, PhD
Institution: Yale University


Improving diagnostic precision of melanoma using genetic information

Team Award 2014
Principal Investigator: Julide Celebi, MD
Institution: Icahn School of Medicine at Mount Sinai


Identifying rational therapeutic approaches to ‘wild type’ melanoma

Team Award 2014
Principal Investigator: Michael Davies, MD, PhD
Institution: University of Texas MD Anderson Cancer Center


Monitoring response to therapy with blood BRAF levels

Team Award 2014
Principal Investigator: Ryan Sullivan, MD
Institution: Massachusetts General Hospital

MRFBC Funded


Targeting PSGL-1 as a novel immunotherapeutic approach to treat melanoma

Established Investigator Award 2014
Principal Investigator: Linda Bradley
Institution: Sanford-Burnham Medical Research Institute


A novel Stat3 targeted acral melanoma therapy via induction of senescence

Established Investigator Award 2014
Principal Investigator: Rutao Cui
Institution: Trustees of Boston University, BU Medical Campus


Fast cycling Gaq Ga11

Established Investigator – CURE OM 2014
Principal Investigator: John Sondek
Institution: University of North Carolina at Chapel Hill

CURE OM funded award


The role of epigenomic alterations in melanoma formation and metastasis

Career Development Award 2014
Principal Investigator: Brian Capell
Institution: University of Pennsylvania